The Benefits of AI for Earlier Autosomal Dominant Polycystic Kidney Disease (ADPKD) Risk Identification

Dr. Andrew Steele, Medical Director and Section Chief of Nephrology and Diabetes at Lakeridge Health.

Dr. Nadia Alam, Primary Care Physician in Halton, U of T Faculty and Past President of the OMA.

After participating in the online live event, physicians should be able to:

  • Provide an overview of ADPKD, clinical manifestations and presentation, differential diagnosis including laboratory and ultrasound, and support for the PCP’s in the referral process.
  • Describe the benefits of AI-enabled Clinical Intelligence as a decision-support tool in rare disease patient identification in a busy Primary Care Physician practice, along with its application to assist with ADPKD patient identification and care pathway optimization.

This live stream has been supported by an educational grant from Khure Health.

Views and opinions in this program are of the faculty and not necessarily endorsed by, or reflective of, those of the publisher of and Journal of Current Clinical Care.